Adam Stefanski is the Associate Vice President of R&D Clinical Research in Cardiometabolic Health at Eli Lilly and Company. They have extensive experience in academia and medical research, having served as an Associate Professor at Pomeranian Medical University from 2008 to 2011 and as a Research Fellow at institutions such as the University of Heidelberg and INSERM. Adam's previous roles at Eli Lilly include Global Medical Advisor and Executive Director of R&D Clinical Research, reflecting a strong background in diabetes and endocrinology. They earned their medical degree and several specialties in internal medicine and diabetes from Pomeranian Medical University, along with a research doctorate in clinical nephrology from the University of Heidelberg.
This person is not in any teams
This person is not in any offices